Switch theme
Sign up to access all valuation multiples
Dallah Healthcare Co provides and operates healthcare programs and utilities in the Kingdom of Saudi Arabia. The objectives of the company include operating, managing and maintaining the healthcare entities, wholesale medicines and retail of medical and surgical equipment, prosthetics and devices for the disabled, hospital equipment and manufacturing medicines, pharmaceuticals, herbals, health, cosmetics, detergents, disinfectants and the packaging in the Kingdom of Saudi Arabia. The reportable segments of the company are Medical Services/Medicine and Pharmaceutical products. The majority of the company's revenue is earned from the Medical service segment.
1994
n/a
LTM Revenue $898M
LTM EBITDA $192M
$3.9B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Dallah Healthcare has a last 12-month revenue of $898M and a last 12-month EBITDA of $192M.
In the most recent fiscal year, Dallah Healthcare achieved revenue of $856M and an EBITDA of $200M.
Dallah Healthcare expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Dallah Healthcare valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $785M | $856M | XXX | XXX | XXX |
| Gross Profit | $239M | $288M | XXX | XXX | XXX |
| Gross Margin | 30% | 34% | XXX | XXX | XXX |
| EBITDA | $168M | $200M | XXX | XXX | XXX |
| EBITDA Margin | 21% | 23% | XXX | XXX | XXX |
| Net Profit | $73.3M | $96.1M | XXX | XXX | XXX |
| Net Margin | 9% | 11% | XXX | XXX | XXX |
| Net Debt | $453M | $443M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Dallah Healthcare's stock price is SAR 128 (or $34).
Dallah Healthcare has current market cap of SAR 13.0B (or $3.5B), and EV of SAR 14.7B (or $3.9B).
See Dallah Healthcare trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $3.9B | $3.5B | XXX | XXX | XXX | XXX | $1.25 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Dallah Healthcare has market cap of $3.5B and EV of $3.9B.
Dallah Healthcare's trades at 4.4x LTM EV/Revenue multiple, and 20.5x LTM EBITDA.
Analysts estimate Dallah Healthcare's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Dallah Healthcare and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $3.9B | XXX | XXX | XXX |
| EV/Revenue | 4.6x | XXX | XXX | XXX |
| EV/EBITDA | 19.6x | XXX | XXX | XXX |
| P/E | 27.6x | XXX | XXX | XXX |
| P/E/Growth | 3.3x | XXX | XXX | XXX |
| EV/FCF | 47.1x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpDallah Healthcare's NTM/LTM revenue growth is 16%
Dallah Healthcare's revenue per employee for the last fiscal year averaged n/a, while opex per employee averaged n/a for the same period.
Over next 12 months, Dallah Healthcare's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Dallah Healthcare's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Dallah Healthcare and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 9% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 23% | XXX | XXX | XXX | XXX |
| EBITDA Growth | 19% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 39% | XXX | XXX | XXX | XXX |
| Revenue per Employee | n/a | XXX | XXX | XXX | XXX |
| Opex per Employee | n/a | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 2% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 4% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| Opex to Revenue | 19% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Burjeel Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| PureHealth | XXX | XXX | XXX | XXX | XXX | XXX |
| Integral Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| Ramsay Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Compass Pathways | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Dallah Healthcare acquired XXX companies to date.
Last acquisition by Dallah Healthcare was XXXXXXXX, XXXXX XXXXX XXXXXX . Dallah Healthcare acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Dallah Healthcare founded? | Dallah Healthcare was founded in 1994. |
| Where is Dallah Healthcare headquartered? | Dallah Healthcare is headquartered in Saudi Arabia. |
| Is Dallah Healthcare publicy listed? | Yes, Dallah Healthcare is a public company listed on SAU. |
| What is the stock symbol of Dallah Healthcare? | Dallah Healthcare trades under 4004 ticker. |
| When did Dallah Healthcare go public? | Dallah Healthcare went public in 2012. |
| Who are competitors of Dallah Healthcare? | Similar companies to Dallah Healthcare include e.g. Burjeel Holdings, PureHealth, Integral Diagnostics, Ramsay Health. |
| What is the current market cap of Dallah Healthcare? | Dallah Healthcare's current market cap is $3.5B |
| What is the current revenue of Dallah Healthcare? | Dallah Healthcare's last 12-month revenue is $898M. |
| What is the current EBITDA of Dallah Healthcare? | Dallah Healthcare's last 12-month EBITDA is $192M. |
| What is the current EV/Revenue multiple of Dallah Healthcare? | Current revenue multiple of Dallah Healthcare is 4.4x. |
| What is the current EV/EBITDA multiple of Dallah Healthcare? | Current EBITDA multiple of Dallah Healthcare is 20.5x. |
| What is the current revenue growth of Dallah Healthcare? | Dallah Healthcare revenue growth between 2023 and 2024 was 9%. |
| Is Dallah Healthcare profitable? | Yes, Dallah Healthcare is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
